Search

everythinglearnresearchcommunity

for

Search:↓

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Men with early-onset hair loss have more heart disease risk factors.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Women with early onset androgenetic alopecia have worse lipid profiles.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Kolaviron and quercetin may help treat prostate issues.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Early hair loss links to metabolic issues in young Indian men.